TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
13,839
|
14,186
|
16,952 |
Financial expenses |
344
|
209
|
41 |
Earnings before taxes |
378
|
557
|
765 |
EBITDA |
534
|
588
|
812 |
Total assets |
9,118
|
11,884
|
20,421 |
Current assets |
8,555
|
11,171
|
18,941 |
Current liabilities |
5,371
|
7,356
|
9,566 |
Equity capital |
2,967
|
2,679
|
2,492 |
- share capital |
90
![]() |
90
|
98 |
Employees (average) |
23
|
18
|
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.5%
|
22.5%
|
12.2% |
Turnover per employee |
602
|
788
|
547 |
Profit as a percentage of turnover |
2.7%
|
3.9%
|
4.5% |
Return on assets (ROA) |
7.9%
|
6.4%
|
3.9% |
Current ratio |
159.3%
|
151.9%
|
198.0% |
Return on equity (ROE) |
12.7%
|
20.8%
|
30.7% |
Change turnover |
-388
|
-1,393
|
-1,454 |
Change turnover % |
-3%
|
-9%
|
-8% |
Chg. No. of employees |
5
|
-13
|
-4 |
Chg. No. of employees % |
28%
|
-42%
|
-11% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.